Catalyst Pharmaceuticals (CPRX) Short-term Investments (2011 - 2022)
Catalyst Pharmaceuticals' (CPRX) quarterly Short-term Investments came in at $9.9 million in Q2 2022, down 50.57% YoY from $20.0 million in Q2 2021, and down 49.16% on a QoQ basis from $19.4 million in Q1 2022.
Catalyst Pharmaceuticals (CPRX) Short-term Investments (2011 - 2022) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 12 years of Short-term Investments data on file, last reported at $9.9 million in Q2 2022.
- Quarterly Short-term Investments fell 50.57% year-over-year to $9.9 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $9.9 million (down 50.57% YoY) and the FY2021 annual result came in at $19.8 million, up 97.4% from the prior year.
- Short-term Investments eased to $9.9 million in Q2 2022, from $19.4 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $58.5 million in Q2 2018 to a low of $5.0 million in Q4 2019.
- A 5-year average of $26.8 million and a median of $20.0 million in 2021 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2018 — Short-term Investments jumped 120.44% — and 2019, when it tumbled 86.44%.
- Tracing CPRX's Short-term Investments over 5 years: stood at $36.9 million in 2018, then plunged by 86.44% to $5.0 million in 2019, then jumped by 100.54% to $10.0 million in 2020, then surged by 97.4% to $19.8 million in 2021, then tumbled by 50.17% to $9.9 million in 2022.
- The last three Short-term Investments figures came in at $9.9 million (Q2 2022), $19.4 million (Q1 2022), and $19.8 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 9.88 Mn |
| Mar 31, 2022 | 19.42 Mn |
| Dec 31, 2021 | 19.82 Mn |
| Sep 30, 2021 | 19.96 Mn |
| Jun 30, 2021 | 19.98 Mn |
| Mar 31, 2021 | 15.97 Mn |
| Dec 31, 2020 | 10.04 Mn |
| Sep 30, 2020 | 10.00 Mn |
| Dec 31, 2019 | 5.01 Mn |
| Sep 30, 2019 | 31.56 Mn |
| Jun 30, 2019 | 36.50 Mn |
| Mar 31, 2019 | 26.55 Mn |
| Dec 31, 2018 | 36.92 Mn |
| Sep 30, 2018 | 51.05 Mn |
| Jun 30, 2018 | 58.52 Mn |
| Mar 31, 2018 | 58.34 Mn |
| Dec 31, 2017 | 26.52 Mn |
| Sep 30, 2017 | 26.58 Mn |
| Jun 30, 2017 | 26.55 Mn |
| Mar 31, 2017 | 26.55 Mn |